This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
MDEA: Difference between revisions
>Josikins m Text replacement - "There are currently no anecdotal reports which describe this compound within our " to "There are currently no anecdotal reports which describe the effects of this compound within our " |
>Unity No edit summary |
||
| Line 6: | Line 6: | ||
| ''[[MDEA/Summary|Summary sheet: MDEA]]'' | | ''[[MDEA/Summary|Summary sheet: MDEA]]'' | ||
|} | |} | ||
'''MDEA''' (also known as '''3,4-methylenedioxy-N-ethylamphetamine''', '''MDE''' or '''Eve''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic drug of the [[phenethylamine]] and [[Chemical class::Substituted amphetamines|substituted amphetamine]] classes and a closely related structural analog of [[MDMA]] and [[MDA]]. | '''MDEA''' (also known as '''3,4-methylenedioxy-N-ethylamphetamine''', '''MDE''' or '''Eve''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic drug of the [[phenethylamine]] and [[Chemical class::Substituted amphetamines|substituted amphetamine]] classes and a closely related structural analog of [[MDMA]] and [[MDA]]. <ref>PiHKAL|http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=106</ref> | ||
In a 1967 lab notebook entry, Alexander Shulgin briefly mentioned a colleague's report of no effect from the substance with a 100mg dose.<ref>Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin|doi=10.1111/j.1360-0443.2010.02948.x}}</ref> Shulgin later tested the compound at a range of higher doses and characterized the substance in his book [[PiHKAL]].<ref>PiHKAL|http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=106</ref> | In a 1967 lab notebook entry, Alexander Shulgin briefly mentioned a colleague's report of no effect from the substance with a 100mg dose.<ref>Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin|doi=10.1111/j.1360-0443.2010.02948.x}}</ref> Shulgin later tested the compound at a range of higher doses and characterized the substance in his book [[PiHKAL]].<ref>PiHKAL|http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=106</ref> | ||